Novel insights regarding mechanisms for treatment of sarcopenia

Metabolism: Clinical and Experimental

Volumn 64, Issue 2, 2015, Pages 160-162

  Kraemer, Robert R ^a   Castracane, V Daniel ^b  

^a SOUTHEASTERN LOUISIANA UNIVERSITY   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; MYOSTATIN; TESTOSTERONE; FSTL3 PROTEIN, MOUSE; PROTEIN;

BLOOD VESSEL OCCLUSION; EDITORIAL; EXERCISE; MUSCLE HYPERTROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN SYNTHESIS; RESISTANCE TRAINING; SARCOPENIA; SKELETAL MUSCLE; ANIMAL; FEMALE; INSULIN RESISTANCE; METABOLISM; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; UPREGULATION;

ADIPOSITY; ANIMALS; FEMALE; INSULIN RESISTANCE; MUSCLE, SKELETAL; PROTEINS; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; UP-REGULATION;

EID: 84920664148     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.11.002     Document Type: Editorial

References (31)

1. A.J. Cruz-Jentoft, F. Landi, S.M. Schneider, C. Zúñiga, H. Arai, and Y. Boirie Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS) Age Ageing 43 6 2014 748 759
2. F. Landi, R. Liperoti, D. Fusco, S. Mastropaolo, D. Quattrociocchi, and A. Proia Prevalence and risk factors of sarcopenia among nursing home older residents J Gerontol A Biol Sci Med Sci 67 1 2012 48 55
3. F. Landi, A.J. Cruz-Jentoft, R. Liperoti, A. Russo, S. Giovannini, and M. Tosato Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study Age Ageing 42 2 2013 203 209
4. S. Gariballa, and A. Alessa Sarcopenia: prevalence and prognostic significance in hospitalized patients Clin Nutr 32 5 2013 772 776
5. S.D. Anton, C. Karabetian, K. Naugle, and T.W. Buford Obesity and diabetes as accelerators of functional decline: can lifestyle interventions maintain functional status in high risk older adults? Exp Gerontol 48 9 2013 888 897
6. W.J. Evans Effects of exercise on body composition and functional capacity of the elderly J Gerontol A Biol Sci Med Sci 50 1995 [Spec No:147-50]
7. Y. Watanabe, H. Madarame, R. Ogasawara, K. Nakazato, and N. Ishii Effect of very low-intensity resistance training with slow movement on muscle size and strength in healthy older adults Clin Physiol Funct Imaging 34 6 2014 463 470
8. B.K. Pedersen, and M.A. Febbraio Muscles, exercise and obesity: skeletal muscle as a secretory organ Nat Rev Endocrinol 8 8 2012 457 465
9. K. Iizuka, T. Machida, and M. Hirafuji Skeletal muscle is an endocrine organ J Pharmacol Sci 125 2 2014 125 131
10. A. Roca-Rivada, O. Al-Massadi, C. Castelao, L.L. Senín, J. Alonso, and L.M. Seoane Muscle tissue as an endocrine organ: comparative secretome profiling of slow-oxidative and fast-glycolytic rat muscle explants and its variation with exercise J Proteomics 75 17 2012 5414 5425
11. B.K. Pedersen, and M.A. Febbraio Muscle as an endocrine organ: focus on muscle-derived interleukin-6 Physiol Rev 88 4 2008 1379 1406
12. D.L. Allen, D.S. Hittel, and A.C. McPherron Expression and function of myostatin in obesity, diabetes, and exercise adaptation Med Sci Sports Exerc 43 10 2011 1828 1835
13. M. Brinkoetter, F. Magkos, M. Vamvini, and C.S. Mantzoros Leptin treatment reduces body fat but does not affect lean body mass or the myostatin-follistatin-activin axis in lean hypoleptinemic women Am J Physiol Endocrinol Metab 301 1 2011 E99 E104
14. R. Ríos, I. Carneiro, V.M. Arce, and J. Devesa Myostatin is an inhibitor of myogenic differentiation Am J Physiol Cell Physiol 282 5 2002 C993 C999
15. C.M. Dieli-Conwright, T.M. Spektor, J.C. Rice, F.R. Sattler, and E.T. Schroeder Hormone therapy and maximal eccentric exercise alters myostatin-related gene expression in postmenopausal women J Strength Cond Res 26 5 2012 1374 1382
16. S. McCroskery, M. Thomas, L. Maxwell, M. Sharma, and R. Kambadur Myostatin negatively regulates satellite cell activation and self-renewal J Cell Biol 162 6 2003 1135 1147
17. T.A. White, and N.K. LeBrasseur Myostatin and sarcopenia: opportunities and challenges - a mini-review Gerontology 60 4 2014 289 293
18. J. Hansen, C. Brandt, A.R. Nielsen, P. Hojman, M. Whitham, and M.A. Febbraio Exercise induces a marked increase in plasma follistatin: evidence that follistatin is a contraction-induced hepatokine Endocrinology 152 1 2011 164 171
19. J.S. Kim, J.M. Cross, and M.M. Bamman Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women Am J Physiol Endocrinol Metab 288 6 2005 E1110 E1119
20. J.S. Kim, J.K. Petrella, J.M. Cross, and M.M. Bamman Load-mediated downregulation of myostatin mRNA is not sufficient to promote myofiber hypertrophy in humans: a cluster analysis J Appl Physiol (1985) 103 5 2007 1488 1495
21. J.L. Mathers, M.M. Farnfield, A.P. Garnham, M.K. Caldow, D. Cameron-Smith, and J.M. Peake Early inflammatory and myogenic responses to resistance exercise in the elderly Muscle Nerve 46 3 2012 407 412
22. A.A. Mero, J.J. Hulmi, H. Salmijärvi, M. Katajavuori, M. Haverinen, and J. Holviala Resistance training induced increase in muscle fiber size in young and older men Eur J Appl Physiol 113 3 2013 641 650
23. C. Brandt, A.R. Nielsen, C.P. Fischer, J. Hansen, B.K. Pedersen, and P. Plomgaard Plasma and muscle myostatin in relation to type 2 diabetes PLoS One 7 5 2012 e37236
24. D.L. Allen, A.S. Cleary, K.J. Speaker, S.F. Lindsay, J. Uyenishi, and J.M. Reed Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice Am J Physiol Endocrinol Metab 294 5 2008 E918 E927
25. J. Henningsen, K.T. Rigbolt, B. Blagoev, B.K. Pedersen, and I. Kratchmarova Dynamics of the skeletal muscle secretome during myoblast differentiation Mol Cell Proteomics 9 11 2010 2482 2496
26. G.C. Laurentino, C. Ugrinowitsch, H. Roschel, M.S. Aoki, A.G. Soares, and M. Neves Strength training with blood flow restriction diminishes myostatin gene expression Med Sci Sports Exerc 44 3 2012 406 412
27. Brandt C, Hanses RH, Hansen JB, Olsen CH, Galle P, Mandrup-Poulsen T, Gehl J, Pedersen BK, Hojman P. Over-expression of follistatin-like 3 attenuates fat accumulation and improves insulin sensitivity in mice. Metabolism (in press).
28. A. Mukherjee, Y. Sidis, A. Mahan, M.J. Raher, Y. Xia, and E.D. Rosen FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults Proc Natl Acad Sci U S A 104 4 2007 1348 1353
29. R.R. Kraemer, D.B. Hollander, G.V. Reeves, M. Francois, Z.G. Ramadan, and B. Meeker Similar hormonal responses to concentric and eccentric muscle actions using relative loading Eur J Appl Physiol 96 5 2006 551 557
30. K. Goto, N. Ishii, T. Kizuka, R.R. Kraemer, Y. Honda, and K. Takamatsu Hormonal and metabolic responses to slow movement resistance exercise with different durations of concentric and eccentric actions Eur J Appl Physiol 106 5 2009 731 739 10.1007/s00421-009-1075-9
31. G.V. Reeves, R.R. Kraemer, D.B. Hollander, J. Clavier, C. Thomas, and M. Francois Comparison of hormone responses following light resistance exercise with partial vascularocclusion and moderately difficult resistance exercise without occlusion J Appl Physiol (1985) 101 6 2006 1616 1622